RapidAI announced that it received FDA 510(k) clearance for its Rapid RV/LV tool for detecting pulmonary embolism (PE) severity. San Mateo, California-based RapidAI designed Rapid RV/LV to quickly assess the ratio between right ventricle and left ventricle. This RV/LV metric represents a key indicator of PE severity. Automating the process enables the care team to […]
RapidAI
RapidAI wins Frost & Sullivan innovation award
Frost & Sullivan announced today that it recognized RapidAI with its 2022 Global Technology Innovation Leadership Award. RapidAI develops artificial intelligence (AI) algorithms for treating vascular and neurovascular conditions. It offers solutions for stroke diagnosis and triage. Its AI creates high-quality, advanced brain images from non-contrast CT, CT angiography, CT perfusion and MRI diffusion and […]
FDA clears RapidAI platform for assessing neuro injury severity
RapidAI announced today that it received FDA clearance for its Rapid Hyperdensity, a new addition to its RapidAI platform. San Mateo, California-based RapidAI designed Rapid Hyperdensity to give physicians a tool to quickly assess the severity of injury in patients with acute neuro conditions, such as traumatic brain injury and brain hemorrhages, to allow for […]
FDA clears RapidAI’s pulmonary embolism triage platform
RapidAI announced today that it received FDA 510(k) clearance for its Rapid PE Triage & Notification product. San Mateo, California-based RapidAI designed its Rapid PE Triage & Notification product for the fast identification and communication of suspected central pulmonary embolism (PE). According to a news release, Rapid PE Triage & Notification works in conjunction with […]
RapidAI launches workflow platform for pulmonary embolism
RapidAI announced today that it launched its mobile and web-based app to aid in the treatment of pulmonary embolism (PE). San Mateo, Calif.-based RapidAI made available the Rapid Workflow for PE, which it designed to align hospital teams on the treatment of patients suspected of having a pulmonary embolism, according to a news release. Rapid […]
RapidAI raises $25M Series B
RapidAI announced today that it raised $25 million in a Series B financing round as it looks to accelerate global growth initiatives. Lennertz & Co. contributed the funds in the financing round, with its managing director Philipp Lennertz saying in a news release that RapidAI’s work has brought “measurable improvement” to patient care around the […]
FDA clears RapidAI blood clot detector
RapidAI announced today that it received FDA clearance for its Rapid LVO system for detecting suspected large vessel occlusions (LVOs). Menlo Park, Calif.-based RapidAI’s Rapid LVO is designed to help physicians speed up triage or transfer decision making. The system uses a vessel tracker, along with an assessment of brain regions with reduced blood vessel […]
